4/A
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-22-032672
Chief Business Officer acquired 113,569 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hannah Brendan · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-19 | Grant or award : show line 1 in the form | +113,569 | 129,793 | D |
Loading xslF345X03/doc4a.xml…